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(iii)1. Current literature highlights
1.1. Carbonic anhydrase inhibitors through dynamic combi-
natorial chemistry
Dynamic combinatorial chemistry (DCC) uses reversible
covalent reactions to synthesise libraries of molecules from
a range of chemical precursors. Unlike conventional syn-
thesis, the intention of DCC is not to generate high yielding
pure compounds, but rather to provide access to a range of
diverse products and enable ampliﬁcation of the ‘best bin-
der’ by interaction of library constituents with a biological
target in a self-screening protocol. A DCC approach has
been used to identify inhibitors of bovine carbonic anhy-
drase II (bCA II).1
The carbonic anhydrases are a family of Zn(II) metallo-
enzymes (EC 4.2.1.1) that catalyse the interconversion of CO2
and HCO3 , a reaction that underpins many physiological
processes associated with the control of pH, ion transport
and ﬂuid secretion. In terms of drug intervention, inhibi-
tors of carbonic anhydrase have been explored clinically
for the treatment of glaucoma, epilepsy and gastric ulcers.
More recently, carbonic anhydrase inhibition has been
implicated as playing an important role in cancer tumour
progression.
This DCC approach to the discovery of bCA II inhibitors
used DCC with alkene cross metathesis (CM) as the revers-
ible reaction. Building block (i), an allyl ester benzene sul-
phonamide, was prepared speciﬁcally as a scaﬀold building
block to facilitate this study, as the precursor contains both
an aromatic sulphonamide moiety to interact with the car-
bonic anhydrase and an allyl substituent, to permit reac-
tion through the CM reaction. The authors elected to use
10 equivalents of the allyl fragment (ii) as the CM partner
of (i), in order to increase the proportion of the heterodi-doi:10.1016/j.comche.2006.06.001
E-mail: nterrett@ensemblediscovery.commer CM products relative to the self-CM product. bCA
II screening results demonstrated that the heterodimer
CM products exhibited variable aﬃnity for bCA II, with
the most potent CM product identiﬁed as (iii) containing
a terminal acetate group. When synthesised as a pure com-
pound, this analogue revealed a Ki value of 4.9 nM.Overall, results for screening against bCA II, without prior
isolation of the active constituent, were in full agreement
with those obtained for equilibrium dissociation constants
(Ki’s) of pure compounds. Some of these compounds dis-
covered exhibited Ki values in the low nanomolar range.
1.2. Libraries from a new Ugi-palladium assisted N-aryl
amidation strategy
Combinatorial chemistry is always in need of more eﬃcient
synthetic strategies for the assembly of interesting and
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(MCR) are an eﬀective way of rapidly generating com-
pound libraries containing a variety of diﬀerent and highly
relevant heterocycles. Amongst the various available MCR
processes, the Ugi reaction is one of the most explored
approaches for rapidly assembling libraries of interesting
chemical products. The area of palladium chemistry is di-
verse and a plethora of post-condensation modiﬁcations
can be envisaged to the Ugi reaction. In a recent paper, a
new strategy for the synthesis of highly substituted N-het-
erocyclic scaﬀolds based on the combination of the Ugi
four-component reaction and a palladium-assisted intra-
molecular N-aryl amidation has been reported.2
The formation of the secondary amide (iv) was originally
reported by Ugi et al via a four component condensation.
The ﬁnal ring-closing reaction was achieved by a classical
intramolecular N-aryl amidation of secondary amides
catalysed by palladium. Speciﬁcally, in the second step of
the reaction sequence, the Ugi-product (iv) was dissolved
in toluene and the N-amidation was performed at 100 C
by using the catalytic system tris(dibenzylideneacetone)
di-palladium Pd2(dba)3, tri-o-tolylphosphine as ligand
and a carbonate base. The expected N-heterocyclic
compounds (for example (v)) were successfully isolated in
moderate to good yields. In addition to substituted ben-
zodiazepin-2,5-diones, appropriate choice of Ugi precur-
sors also permitted the preparation of indol-2-ones, and
quinoxalin-2-ones.R1 NH2
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(v)In summary, a novel two-step solution phase procedure
for the preparation of indol-2-ones, quinoxalin-2-ones
and benzodiazepine-2,5-diones has been described. As
the ﬁnal products, accessed via a facile and rapid produc-
tion protocol, contain four points of potential diversity,
the combinatorial synthesis of thousands of compounds
containing these important pharmacophoric scaﬀolds is
now feasible.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
Seventeen unsymmetrical curcumin derivatives have been
synthesised in good yield and purity by a facile solid phase
synthesis strategy.3
An eﬃcient method for the reduction of aromatic azides in
both solution and on solid-phase has been developed by
employing BF3ÆOEt2/EtSH. This report also describes resin
cleavage employing this reagent system, and the protocol
has been used for the solid-phase synthesis of pyrrolo[2,1-c]-
[1,4]benzodiazepines, including the naturally occurring anti-
biotic DC-81 and fused [2,1-b]quinazolinones.4
A stereoselective synthesis of dinucleoside boranophos-
phates by using nucleoside 3 0-oxazaphospholidine deriva-
tives has been described. (Rp)- and (Sp)-dithymidine
boranophosphates were synthesisedwith excellent diastereo-
selectivity both in solution and on a solid-support.5
The preparation of three diﬀerent 2-alkoxy-8-hydroxyade-
nylpeptide conjugates has been accomplished by solid-
phase synthesis combined with ‘on-resin’ Cu(I) catalyzed
Huisgen cycloaddition.6
An eﬃcient and straightforward methodology for the
parallel solid-phase synthesis of a variety of new macro-
cyclic oligoheterocycles is described. Exhaustive reduction
of resin-bound cyclic polyamides using borane generates
polyamines, and treatment of separated pairs of amines
with a variety of bifunctional reagents provides, follow-
ing cleavage from the solid support, the desired macro-
cyclic oligoheterocyclic compounds in good yields and
purities.72.2. Solution-phase synthesis
A diversity-oriented synthetic approach toward skeletally
diverse, cyclised peptidomimetics with diverse appendages
has been reported. Starting from a-(N-acylamino)amides
with various appendages, 12 to 16-membered lactams with
deﬁned oleﬁn geometry were synthesised by a common syn-
thetic sequence, directed toward a construction of a pepti-
domimetic library.8
A method for the preparation of oxybispyridines bearing
several halogens has been described. These compounds,
which could be further modiﬁed with other functional
groups thus giving access to libraries with the bis-pyridyl
ether moiety as the common structural feature, are of inter-
est in cholinergic medicinal chemistry.92.3. Scaﬀolds for combinatorial libraries
The ﬁrst example of the synthesis of isocyanide derivatives
of a-aminoalkylphosphonate diphenyl esters has been
reported. This method permits the generation of an a-amin-
ophosphonate-based library of biologically active phos-
phonopeptides.10
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rylic aldehydes, bromoanilines, acids and isocyanides yield-
ing polysubstituted indoles has been described, based on
the combination of an Ugi four-component reaction fol-
lowed by an intramolecular Heck-reaction. The simulta-
neous use of formic acid and cinnamaldehydes aﬀords
in situ generation of 1H-indoles suitable for a combinato-
rial approach.11
A small library of 2-oxo-5-(hetero)arylpyrroles has been
prepared starting from 2,3-dioxo-5-(hetero)arylpyrrol-
idines. The 2-oxopyrroles oﬀer a large number of possible
derivatisations including reactions with electrophiles and
are thus interesting and versatile synthetic building blocks.122.4. Solid-phase supported reagents
Amphiphilic polymer-supported N-heterocyclic carbene
(NHC) precursor resins have been generated by loading
polyethylene glycol (PEG) containing imidazolium groups
on Merriﬁeld resin. These PS–PEG–NHC–Pd catalysts
showed better catalytic activity for Suzuki cross-coupling
reactions of various aryl iodides and bromides with phen-
ylboronic acid in water than the previously described poly-
styrene based catalysts.13
The synthesis of the major metabolite of a potent 3-amino-
pyrazole CDK2/cyclin A inhibitor has been presented. A
stereoconservative approach starting from malic acid was
employed to construct the hydroxy-substituted pyrroli-
dinone moiety. In the key step of the synthesis the use of
cyanoborohydride immobilized on Amberlyst 26 in triﬂuo-
roethanol represented a valid alternative to conventional
solution-phase reducing agents.14
2.5. Novel resins, linkers and techniques
No papers this month.2.6. Library applications
A small library of squamocin analogues has been prepared
and screened biologically (cytotoxicity, inhibition of mito-
chondrial complex I and complex III). To centre diversity
on a crucial part of the molecule (i.e., the a,b-unsaturated
lactone), an original and reliable lactone opening reaction
has been discovered.15
Two small libraries of tripeptidic-based vinyl ester deriva-
tive proteasome inhibitors have been synthesised and
tested, starting with the Hmb-Val-Gln-Leu-VE prototype.
The P3 and P4 positions were investigated with a complete
set of amino acid residues, some of which showed remark-
able selective inhibition of the trypsin-like (b2) subunit.16
A recent study reports the generation of a focused library
of Lisofylline (LSF) analogs that maintain the side chain
(5-R-hydroxyhexyl) constant, while substituting a variety
of nitrogen-containing heterocyclic substructures for the
xanthine moiety of LSF. The LSF analogues were evalu-
ated in a pancreatic b-cell line for the eﬀects on apoptosis
protection and insulin release.17A library consisting of 60 arylpiperazines modiﬁed with
N-acylated amino acids have been prepared on BAL linker
SynPhaseTM Lanterns and evaluated in vitro for 5-HT1A
receptor aﬃnity. Biological screening, followed by a simple
Fujita–Ban analysis, enabled the description of structure–
activity relationships and allowed the selection of some po-
tent, high-aﬃnity ligands for in vivo pharmacological
investigations.18
Using a scaleable, directed library approach based on
orthogonally protected advanced intermediates, a series of
potent keto-1,2,4-oxadiazoles have been prepared. This
library was designed to explore the P2 binding pocket of
human mast cell tryptase, while building in a high degree
of selectivity over human trypsin and other serine
proteases.19
New non-steroidal chemotypes are required for the develop-
ment of drugs targeting the steroid hormone receptors. The
parallel array synthesis of 3-aryl-1,2-diazepines employing
solid-supported reagents has been described, and the result-
ing compounds demonstrated high aﬃnity binding to the
progesterone receptor.20
Potential inhibitors of the Trypanosoma cruzi dUTP nucle-
otidohydrolase have been docked into the enzyme using the
program FlexX. Compounds that docked selectively were
then synthesised using solid phase methodology, giving rise
to a novel library of amino acid uracil acetamide com-
pounds which were evaluated for enzyme inhibition and
anti-parasitic activity.21
The synthesis and screening of a biased positional scanning
library made up of peptoids (N-alkylglycines) and lysines
has been described. A theoretical number of 390,625 com-
pounds were synthesised and screened against the Ameri-
can Type Culture Collection (ATCC) Staphylococcus
aureus ATCC 25923 and Escherichia coli ATCC 25922 bac-
terial strains, and the cytotoxic activities were assessed
using a human blood hemolytic assay.22
With the aim of developing small molecular non-peptide b-
secretase (BACE) inhibitors, Leu-Ala hydroxyethylene
(HE) has been investigated as a scaﬀold to design and syn-
thesise a series of compounds. Taking advantage of eﬃ-
cient combinatorial synthesis approaches and molecular
modelling, extensive structure–activity relationship (SAR)
studies were carried out on the N- and C-terminal residues
of the scaﬀold.23
Pyranocoumarin compounds have been identiﬁed to em-
body a novel and unique pharmacophore for anti-TB activ-
ity, and a systematic approach was taken to investigate the
structural characteristics. Focused libraries of compounds
were synthesised and evaluated for their anti-TB activity
in primary screening assays.24
The condensation of a set of diversely substituted (S)-2-
amino-2-ferrocenyl ethanol derivatives with salicylalde-
hydes resulted in the generation of a small library of new
chiral Schiﬀ base-ligands, whose titanium isopropoxide
complexes have been tested as catalysts in the asymmetric
addition of trimethylsilyl cyanide to aldehydes.25
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10,000 known bioactive small molecules, natural products,
and small molecules originating from several diversity-ori-
ented syntheses have been produced by using an isocya-
nate-mediated covalent capture strategy. The new surface
of the diversity microarrays is highly compatible with ap-
proaches involving cellular lysates, and this has enabled a
robust, optimized screening methodology, allowing the
detection of speciﬁc interactions.26References
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